126 related articles for article (PubMed ID: 9030241)
41. Ionizing radiation induces up-regulation of functional beta1-integrin in human lung tumour cell lines in vitro.
Cordes N; Blaese MA; Meineke V; Van Beuningen D
Int J Radiat Biol; 2002 May; 78(5):347-57. PubMed ID: 12020426
[TBL] [Abstract][Full Text] [Related]
42. beta 1-Integrin expression and function in human bladder cancer cells: modulation by TNF alpha.
Nista A; Mattioni M; Gismondi A; Palmieri G; Santoni A
Anticancer Res; 1996; 16(2):581-8. PubMed ID: 8687101
[TBL] [Abstract][Full Text] [Related]
43. Glomerular epithelial and mesangial cells differentially modulate the binding specificities of VLA-1 and VLA-2.
Mendrick DL; Kelly DM; duMont SS; Sandstrom DJ
Lab Invest; 1995 Mar; 72(3):367-75. PubMed ID: 7898055
[TBL] [Abstract][Full Text] [Related]
44. miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.
Long QZ; Du YF; Liu XG; Li X; He DL
Tumour Biol; 2015 Sep; 36(9):7017-26. PubMed ID: 25861751
[TBL] [Abstract][Full Text] [Related]
45. Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors.
Efferth T; Löhrke H; Volm M
Anticancer Res; 1989; 9(6):1633-7. PubMed ID: 2576349
[TBL] [Abstract][Full Text] [Related]
46. Extracellular matrix and beta 1 integrin expression in nodal and extranodal T-cell lymphomas.
Jaspars LH; Bonnet P; Bloemena E; Meijer CJ
J Pathol; 1996 Jan; 178(1):36-43. PubMed ID: 8778313
[TBL] [Abstract][Full Text] [Related]
47. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro.
Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M
Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470
[TBL] [Abstract][Full Text] [Related]
48. Expression and function of fibronectin receptors on peripheral mononuclear cells in IgA nephropathy.
Namie S; Ozono Y; Harada T; Hara K
Nephrol Dial Transplant; 1995; 10(8):1342-7. PubMed ID: 8538924
[TBL] [Abstract][Full Text] [Related]
49. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
Yu DS; Chang SY; Ma CP
Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
[TBL] [Abstract][Full Text] [Related]
50. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas.
Mickisch GH; Kössig J; Keilhauer G; Schlick E; Tschada RK; Alken PM
Cancer Res; 1990 Jun; 50(12):3670-4. PubMed ID: 2340516
[TBL] [Abstract][Full Text] [Related]
51. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
Kakehi Y; Segawa T; Hashimura T; Yoshida O
Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
[TBL] [Abstract][Full Text] [Related]
52. Fibrolamellar carcinoma of the liver: composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules.
Scoazec JY; Flejou JF; D'Errico A; Fiorentino M; Zamparelli A; Bringuier AF; Feldmann G; Grigioni WF
Hepatology; 1996 Nov; 24(5):1128-36. PubMed ID: 8903387
[TBL] [Abstract][Full Text] [Related]
53. [VLA and alpha6, beta4 integrins. Expression in normal and neoplastic human tissues].
Hofman P; Colas P; Manie S; Beck A; D'Andrea L
Arch Anat Cytol Pathol; 1995; 43(5-6):309-24. PubMed ID: 8729847
[TBL] [Abstract][Full Text] [Related]
54. Induction of the connexin 32 gene by epigallocatechin-3-gallate potentiates vinblastine-induced cytotoxicity in human renal carcinoma cells.
Sato A; Sekine M; Kobayashi M; Virgona N; Ota M; Yano T
Chemotherapy; 2013; 59(3):192-9. PubMed ID: 24335094
[TBL] [Abstract][Full Text] [Related]
55. Verapamil modulation of multidrug resistance in renal cell carcinoma.
Yu DS; Sun GH; Ma CP; Chang SY
J Formos Med Assoc; 2000 Apr; 99(4):311-6. PubMed ID: 10870315
[TBL] [Abstract][Full Text] [Related]
56. Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas.
Miettinen M; Castello R; Wayner E; Schwarting R
Am J Pathol; 1993 Apr; 142(4):1009-18. PubMed ID: 7682756
[TBL] [Abstract][Full Text] [Related]
57. Loss of VLA-3 (CD49c/CD29) expression in two multidrug resistant Burkitt's lymphoma cell lines.
Duensing S; Duensing A; Grosse J; Atzpodien J
Cancer Biother Radiopharm; 1998 Oct; 13(5):369-73. PubMed ID: 10851427
[TBL] [Abstract][Full Text] [Related]
58. Disruption of cell adhesion in renal epithelium without cadherin loss.
O'Donnell M; Fleming S
J Pathol; 1995 Jan; 175(1):45-50. PubMed ID: 7891226
[TBL] [Abstract][Full Text] [Related]
59. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
Sedlák J; McGown A; Hrubisko M; Hunáková L; Chorváth B
Neoplasma; 1994; 41(5):259-62. PubMed ID: 7854495
[TBL] [Abstract][Full Text] [Related]
60. In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.
Hathorn RW; Tso CL; Kaboo R; Pang S; Figlin R; Sawyers C; deKernion JB; Belldegrun A
Cancer; 1994 Oct; 74(7):1904-11. PubMed ID: 7521786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
